CELESTONE Side Effects

7015547-1 | Abdominal Pain Lower, Fatigue, Foetal Hypokinesia, Nausea
on Sep 08, 2010 Female patient from FRANCE , 17 years of age, was diagnosed with threatened labour and was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, fatigue, foetal hypokinesia, nausea (What is nausea?). Celestone dosage: 12 Mg;once;im. Patient was hospitalized.

7007737-9 | Blood Pressure Decreased, Brain Natriuretic Peptide Increased, Cardiac Failure, Cardiomyopathy, Chest Pain, Dyspnoea, Escherichia Test Positive, Pleural Effusion
Patient was taking Celestone (View Usage). Patient had the following side effects: blood pressure decreased, brain natriuretic peptide increased, cardiac failure, cardiomyopathy (What is cardiomyopathy?), chest pain (What is chest pain?), dyspnoea, escherichia test positive, pleural effusion on Sep 13, 2010 from FRANCE Additional patient health information: Female patient , 29 years of age, was diagnosed with tocolysis, infection prophylaxis and. Celestone dosage: . During the same period patient was treated with NIFEDIPINE (1 Df; Qd; Po) (View Nifedipine Review and Nifedipine Label ), TRACTOCILE (ATOSIBAN) (View Tractocile (atosiban) Review and Tractocile (atosiban) Label ), ERYTHROMYCIN (3 Gm; Qd;) (View Erythromycin Review and Erythromycin Label ), PHENYLEPHRINE HCL (View Phenylephrine Hcl Review and Phenylephrine Hcl Label ), VOLUVEN (View Voluven Review and Voluven Label ). Patient was hospitalized.

6945810-1 | Eyelid Oedema, Hypotension, Lip Oedema, Pharyngeal Oedema, Respiratory Disorder, Urticaria
Adverse event was reported on Aug 10, 2010 by a Female patient taking Celestone (View Usage) (Dosage: Po) was diagnosed with ill-defined disorder and. Location: FRANCE , 54 years of age, After Celestone was administered, patient had the following side effects: eyelid oedema, hypotension, lip oedema, pharyngeal oedema, respiratory disorder, urticaria. During the same period patient was treated with VISCERALGINE (TIEMONIUM MESILATE) (50 Mg;qd;po) (View Visceralgine (tiemonium Mesilate) Review and Visceralgine (tiemonium Mesilate) Label ), FELDENE (Po) (View Feldene Review and Feldene Label ), SPASFON (SPASFON /00765801/) (Po) (View Spasfon (spasfon /00765801/) Review and Spasfon (spasfon /00765801/) Label ). Patient was hospitalized.

6862706-4 | Cough, Dyspnoea, Erythema, Flushing, Swelling Face
on Jul 12, 2010 Female patient from FRANCE , 51 years of age, weighting 145.5 lb, was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, erythema, flushing, swelling face. Celestone dosage: . During the same period patient was treated with BI PROFENID (View Bi Profenid Review and Bi Profenid Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), AVAMYS (View Avamys Review and Avamys Label ), AERIUS (View Aerius Review and Aerius Label ).


6855978-3 | No Adverse Event
on Jul 16, 2010 Female patient from UNITED STATES , 84 years of age, weighting 99.00 lb, was diagnosed with aspiration joint and was treated with Celestone (View Usage). Patient had the following side effects: no adverse event. Celestone dosage: .

6815480-1 | Erythema, Respiratory Disorder
Patient was taking Celestone (View Usage). After Celestone was administered, patient had the following side effects: erythema, respiratory disorder on Jun 23, 2010 from FRANCE Additional patient health information: Female patient , 51 years of age, . Celestone dosage: . During the same period patient was treated with BI PROFENID (View Bi Profenid Review and Bi Profenid Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), AVAMYS (View Avamys Review and Avamys Label ), AERIUS (View Aerius Review and Aerius Label ).

6800201-9 | Anaphylactic Shock, Bronchospasm, Formication, Urticaria
Adverse event was reported on Jun 11, 2010 by a Female patient taking Celestone (View Usage) (Dosage: ; Once; Im) . Location: FRANCE , 61 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, bronchospasm, formication, urticaria. During the same period patient was treated with ROCEPHIN (; Once; Im) (View Rocephin Review and Rocephin Label ).

6791370-8 | Anaphylactic Shock, Blood Pressure Decreased, Bronchospasm, Formication
on Jun 17, 2010 Female patient from FRANCE , 61 years of age, was treated with Celestone (View Usage). Patient had the following side effects: anaphylactic shock, blood pressure decreased, bronchospasm, formication. Celestone dosage: ;once ;im. During the same period patient was treated with ROCEPHIN (;once ;im) (View Rocephin Review and Rocephin Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ), LASIX (View Lasix Review and Lasix Label ), CORVASAL (View Corvasal Review and Corvasal Label ), SINGULAIR (View Singulair Review and Singulair Label ), NEXIUM (View Nexium Review and Nexium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6769086-3 | Adrenal Neoplasm, Arteriosclerosis, Hernia Pain, Hypertension, Renal Cyst
on May 25, 2010 Female patient from FRANCE , 57 years of age, was diagnosed with otitis media and was treated with Celestone (View Usage). After Celestone was administered, patient had the following side effects: adrenal neoplasm, arteriosclerosis, hernia pain, hypertension, renal cyst. Celestone dosage: 4 Mg; Qam; Po. During the same period patient was treated with TAVANIC (View Tavanic Review and Tavanic Label ), ACTISOUFRE (View Actisoufre Review and Actisoufre Label ), NIFLURIL (View Nifluril Review and Nifluril Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), CODEINE SUL TAB (View Codeine Sul Tab Review and Codeine Sul Tab Label ), LERCAN (View Lercan Review and Lercan Label ), APROVEL (View Aprovel Review and Aprovel Label ), SOLUPRED (View Solupred Review and Solupred Label ).

6742811-3 | Spinal Cord Infarction
Patient was taking Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: spinal cord infarction on May 04, 2010 from UNITED STATES Additional patient health information: Female patient , 83 years of age, was diagnosed with pain management and. Celestone dosage: 1 Cc (6 Mg/cc). During the same period patient was treated with ISOVUE 300 (View Isovue-300 Review and Isovue-300 Label ), BUPIVACAINE HCL (View Bupivacaine Hcl Review and Bupivacaine Hcl Label ).

6703395-9 | Confusional State, Hallucination, White Blood Cell Count Increased
Adverse event was reported on Apr 23, 2010 by a Male patient taking Celestone (View Usage) (Dosage: 0.5 Mg; Bid;) was diagnosed with rash (What is rash?) and. Location: BELGIUM , 32 years of age, Patient had the following side effects: confusional state, hallucination, white blood cell count increased. Patient was hospitalized.

6696361-3 | Anaphylactic Reaction, Convulsion, Dialysis, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Hepatic Enzyme Increased, Hypoxic Encephalopathy, Loss Of Consciousness, Multi-organ Failure
on Apr 16, 2010 Female patient from SOUTH AFRICA , 45 years of age, was diagnosed with headache (What is headache?) and was treated with Celestone (View Usage). After Celestone was administered, patient had the following side effects: anaphylactic reaction, convulsion, dialysis (What is dialysis?), gastrointestinal haemorrhage, haemoglobin decreased, hepatic enzyme increased, hypoxic encephalopathy, loss of consciousness, multi-organ failure. Celestone dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), PARECOXIB SODIUM (40 Mg;once;im) (View Parecoxib Sodium Review and Parecoxib Sodium Label ). Patient was hospitalized.

6691416-1 | Convulsion, Multi-organ Failure
on Apr 13, 2010 Female patient from SOUTH AFRICA , 45 years of age, was diagnosed with headache (What is headache?) and was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, multi-organ failure. Celestone dosage: . During the same period patient was treated with VOLTAREN (View Voltaren Review and Voltaren Label ), RAYZON (PARECOXIB SODIUM) (View Rayzon (parecoxib Sodium) Review and Rayzon (parecoxib Sodium) Label ). Patient was hospitalized.

6688881-2 | Agitation, Crying, Hypertonia, Musculoskeletal Stiffness, Screaming, Staring
Patient was taking Celestone (View Usage). Patient had the following side effects: agitation, crying, hypertonia, musculoskeletal stiffness, screaming, staring on Apr 09, 2010 from FRANCE Additional patient health information: Male patient , weighting 29.54 lb, was diagnosed with laryngitis and. Celestone dosage: 140 Gtt; Qd; Po. During the same period patient was treated with MAXILASE (View Maxilase Review and Maxilase Label ). Patient was hospitalized.

6652477-9 | Agitation, Hypertonia, Lacrimation Increased, Musculoskeletal Stiffness, Screaming
Adverse event was reported on Mar 15, 2010 by a Male patient taking Celestone (View Usage) (Dosage: 140 Gtt;qd;po) was diagnosed with laryngitis and. Location: FRANCE , weighting 29.54 lb, After Celestone was administered, patient had the following side effects: agitation, hypertonia, lacrimation increased, musculoskeletal stiffness, screaming. During the same period patient was treated with MAXILASE (View Maxilase Review and Maxilase Label ). Patient was hospitalized.

6642706-X | Hallucination, Visual
on Mar 10, 2010 Female patient from FRANCE , 73 years of age, was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, visual. Celestone dosage: Po. During the same period patient was treated with DESLORATADINE (Po) (View Desloratadine Review and Desloratadine Label ), CEFPODOXIME PROXETIL (Po) (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), TRAMADOL HCL (100 Mg;bid;po) (View Tramadol Hcl Review and Tramadol Hcl Label ), NISIS (CON.) (View Nisis (con.) Review and Nisis (con.) Label ), ESIDREX (CON.) (View Esidrex (con.) Review and Esidrex (con.) Label ), FUROSEMIDE (CON.) (View Furosemide (con.) Review and Furosemide (con.) Label ), TAHOR (CON.) (View Tahor (con.) Review and Tahor (con.) Label ), TRIVASTAL (CON.) (View Trivastal (con.) Review and Trivastal (con.) Label ). Patient was hospitalized.

6639202-2 | Blister, Diarrhoea, Erythema
on Mar 09, 2010 Female patient from FRANCE , 70 years of age, was diagnosed with back pain (What is back pain?) and was treated with Celestone (View Usage). Patient had the following side effects: blister, diarrhoea, erythema. Celestone dosage: Df; Once. During the same period patient was treated with SURGAM (TIAPROFENIC ACID) (View Surgam (tiaprofenic Acid) Review and Surgam (tiaprofenic Acid) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), COLCHICIN (View Colchicin Review and Colchicin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), TAREG (View Tareg Review and Tareg Label ), VASTEN (View Vasten Review and Vasten Label ). Patient was hospitalized.

6627638-5 | Hallucination, Visual
Patient was taking Celestone (View Usage). After Celestone was administered, patient had the following side effects: hallucination, visual on Mar 03, 2010 from FRANCE Additional patient health information: Female patient , 73 years of age, . Celestone dosage: ;po. During the same period patient was treated with DESLORATADINE (;po) (View Desloratadine Review and Desloratadine Label ), CEFPODOXIME PROXETIL (;po) (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), TRAMADOL HCL (100 Mg;bid;po) (View Tramadol Hcl Review and Tramadol Hcl Label ), NISIS (View Nisis Review and Nisis Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TAHOR (View Tahor Review and Tahor Label ), TRIVASTAL (View Trivastal Review and Trivastal Label ). Patient was hospitalized.

6578711-1 | No Adverse Event
Adverse event was reported on Jan 26, 2010 by a Female patient taking Celestone (View Usage) (Dosage: ) was diagnosed with acute respiratory distress syndrome and. Location: GERMANY , child 8. years of age, Patient experienced the following unwanted or unexpected effects: no adverse event.

6571274-6 | Arrhythmia, Bradycardia, Tachycardia
on Jan 22, 2010 Female patient from FRANCE , child 5 years of age, weighting 44.09 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Celestone (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), bradycardia, tachycardia. Celestone dosage: 200 Gtt;qam;po. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ).

6425182-1 | Injection Site Discolouration, Injection Site Haematoma, Injection Site Reaction, Joint Injury, Menstruation Irregular, Nerve Injury, Skin Disorder
on Nov 02, 2009 Female patient from UNITED STATES , 34 years of age, weighting 160.0 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Celestone (View Usage). After Celestone was administered, patient had the following side effects: injection site discolouration, injection site haematoma, injection site reaction, joint injury, menstruation irregular, nerve injury, skin disorder. Celestone dosage: Once Other.

6423597-9 | Amnesia, Anaphylactic Shock, Blood Pressure Increased, Fall, Loss Of Consciousness, Musculoskeletal Stiffness, Myalgia, Tremor
Patient was taking Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, anaphylactic shock, blood pressure increased, fall (What is fall?), loss of consciousness, musculoskeletal stiffness, myalgia, tremor on Oct 23, 2009 from FRANCE Additional patient health information: Female patient , 71 years of age, weighting 116.8 lb, was diagnosed with sciatica (What is sciatica?) and. Celestone dosage: Once. During the same period patient was treated with URISPAS (View Urispas Review and Urispas Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), COLPOTROPHINE (View Colpotrophine Review and Colpotrophine Label ), OROCAL (View Orocal Review and Orocal Label ), FORLAX (View Forlax Review and Forlax Label ), PIASCLEDINE (View Piascledine Review and Piascledine Label ), CHONDROSULF (View Chondrosulf Review and Chondrosulf Label ).

6403187-4 | Amnesia, Fall, Tremor
Adverse event was reported on Sep 30, 2009 by a Female patient taking Celestone (View Usage) (Dosage: ) was diagnosed with sciatica (What is sciatica?) and. Location: FRANCE , 71 years of age, Patient had the following side effects: amnesia, fall (What is fall?), tremor. During the same period patient was treated with URISPAS (CON.) (View Urispas (con.) Review and Urispas (con.) Label ), SIMVASTATIN (CON.) (View Simvastatin (con.) Review and Simvastatin (con.) Label ), COLPOTROPHINE (CON.) (View Colpotrophine (con.) Review and Colpotrophine (con.) Label ).

6398517-6 | Amnesia, Fall, Product Substitution Issue, Tremor
on Sep 30, 2009 Female patient from FRANCE , 71 years of age, was diagnosed with sciatica (What is sciatica?) and was treated with Celestone (View Usage). After Celestone was administered, patient had the following side effects: amnesia, fall (What is fall?), product substitution issue, tremor. Celestone dosage: . During the same period patient was treated with URISPAS (View Urispas Review and Urispas Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), COLPOTROPHINE (View Colpotrophine Review and Colpotrophine Label ).

6342055-3 | Anaemia Neonatal, Caesarean Section, Cerebral Cyst, Hyperbilirubinaemia Neonatal, Hypernatraemia, Hypokalaemia, Neonatal Disorder, Neonatal Hypotension
on Aug 05, 2009 Female patient from SWITZERLAND , weighting 1.54 lb, was diagnosed with essential hypertension and was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia neonatal, caesarean section, cerebral cyst, hyperbilirubinaemia neonatal, hypernatraemia, hypokalaemia, neonatal disorder, neonatal hypotension. Celestone dosage: Trpl. During the same period patient was treated with NORVASC (Trpl) (View Norvasc Review and Norvasc Label ), TRANDATE (Trpl) (View Trandate Review and Trandate Label ), PENICILLIN G (Trpl) (View Penicillin G Review and Penicillin G Label ), ERYTHROMYCIN (Trpl) (View Erythromycin Review and Erythromycin Label ), GYNIPRAL (View Gynipral Review and Gynipral Label ). Patient was hospitalized.

6313410-2 | Anxiety, Confusional State, Dizziness, Hypertension, Palpitations, Tinnitus
Patient was taking Celestone (View Usage). Patient had the following side effects: anxiety (What is anxiety?), confusional state, dizziness (What is dizziness?), hypertension, palpitations, tinnitus (What is tinnitus?) on Aug 14, 2009 from UNITED STATES Additional patient health information: Male patient , 52 years of age, weighting 175.0 lb, was diagnosed with viral infection (What is viral infection?) and. Celestone dosage: 12 Mg 1 Dose Im.

6243237-1 | Cardiac Failure Congestive, Diabetes Mellitus, Hepatic Cirrhosis, Pain, Weight Increased
Adverse event was reported on Jun 22, 2009 by a Female patient taking Celestone (View Usage) (Dosage: 1 To 1 1/2 Cc One Time) was diagnosed with arthritis (What is arthritis?) and. Location: UNITED STATES , 68 years of age, weighting 220.0 lb, After Celestone was administered, patient had the following side effects: cardiac failure congestive, diabetes mellitus, hepatic cirrhosis, pain (What is pain?), weight increased. Patient was hospitalized.

6122579-4 | Dizziness, Impatience, Increased Appetite, Insomnia, Musculoskeletal Pain, Nausea, Neck Pain, Pain In Extremity
on Mar 16, 2009 Female patient from UNITED STATES , 61 years of age, weighting 260.0 lb, was diagnosed with rotator cuff syndrome and was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), impatience, increased appetite, insomnia, musculoskeletal pain, nausea (What is nausea?), neck pain, pain in extremity. Celestone dosage: 1 Cc First Time Im.

6074488-7 | Condition Aggravated, Conjunctivitis, Eosinophilia, Erythema Multiforme, Hypersensitivity, Inflammation, Lymphopenia, Stevens-johnson Syndrome, Vision Blurred
on Feb 02, 2009 Female patient from FRANCE , 51 years of age, was treated with Celestone (View Usage). Patient had the following side effects: condition aggravated, conjunctivitis, eosinophilia, erythema multiforme, hypersensitivity, inflammation, lymphopenia, stevens-johnson syndrome, vision blurred. Celestone dosage: 1 Df; Once; Im. During the same period patient was treated with PREDNISOLONE (60 Mg; Qd; Po) (View Prednisolone Review and Prednisolone Label ), N ACETYL ASPARTYL GLUTAMIC ACID (ISOSPAGLUMIC ACID) (Oph) (View N-acetyl Aspartyl Glutamic Acid (isospaglumic Acid) Review and N-acetyl Aspartyl Glutamic Acid (isospaglumic Acid) Label ), BECONASE (Nas) (View Beconase Review and Beconase Label ), ENOXOLONE (ENOXOLONE) (Top) (View Enoxolone (enoxolone) Review and Enoxolone (enoxolone) Label ). Patient was hospitalized.

6054976-X | Acute Pulmonary Oedema, Chills, Pleural Effusion, Pre-eclampsia
Patient was taking Celestone (View Usage). After Celestone was administered, patient had the following side effects: acute pulmonary oedema, chills, pleural effusion, pre-eclampsia on Jan 16, 2009 from FRANCE Additional patient health information: Female patient , 28 years of age, . Celestone dosage: . During the same period patient was treated with NICARDIPINE HCL (30 Mg, Q12h; Iv) (View Nicardipine Hcl Review and Nicardipine Hcl Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ).

5989192-0 | Brain Oedema, Hypertensive Crisis, International Normalised Ratio Increased, Subarachnoid Haemorrhage, Subdural Haemorrhage
Adverse event was reported on Dec 01, 2008 by a Female patient taking Celestone (View Usage) (Dosage: 1 Df; Once; Iv) . Location: FRANCE , 90 years of age, Patient experienced the following unwanted or unexpected effects: brain oedema, hypertensive crisis, international normalised ratio increased, subarachnoid haemorrhage, subdural haemorrhage. During the same period patient was treated with PREVISCAN (FLUINDIONE) (0.25 Df; Qd; Po) (View Previscan (fluindione) Review and Previscan (fluindione) Label ), ACETAMINOPHEN (600 Mg; Once; Rtl) (View Acetaminophen Review and Acetaminophen Label ), LASIX (1 Df; Once; Iv) (View Lasix Review and Lasix Label ). Patient was hospitalized.

5930354-6 | Stevens-johnson Syndrome
on Oct 15, 2008 Male patient from SOUTH AFRICA , 45 years of age, was diagnosed with gout (What is gout?) and was treated with Celestone (View Usage). Patient had the following side effects: stevens-johnson syndrome. Celestone dosage: Iv.

5878603-7 | Blast Cell Count Increased, Blood Disorder, White Blood Cell Count Increased
on Aug 25, 2008 Female patient from BELGIUM , 35 years of age, was treated with Celestone (View Usage). After Celestone was administered, patient had the following side effects: blast cell count increased, blood disorder, white blood cell count increased. Celestone dosage: 12 Mg; Bid.

5785798-2 | Abdominal Pain Upper, Asthenia, Chromaturia, Creatinine Renal Clearance Decreased, Laboratory Test Abnormal, Muscle Spasms, Nausea, Night Sweats, Thrombotic Microangiopathy
Patient was taking Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, asthenia, chromaturia, creatinine renal clearance decreased, laboratory test abnormal, muscle spasms, nausea (What is nausea?), night sweats, thrombotic microangiopathy on Jun 09, 2008 from FRANCE Additional patient health information: Male patient , 58 years of age, was diagnosed with chills, cough, pharyngitis, pyrexia, rhinitis, tracheitis and. Celestone dosage: 2 Mg;qd;po. During the same period patient was treated with CEFUROXIME (250 Mg;bid;po) (View Cefuroxime Review and Cefuroxime Label ). Patient was hospitalized.

5746175-3 | Erythema, Pruritus, Pyrexia, Rash Maculo-papular, Skin Plaque
Adverse event was reported on May 16, 2008 by a Male patient taking Celestone (View Usage) (Dosage: Po) was diagnosed with sinusitis (What is sinusitis?) and. Location: FRANCE , 46 years of age, Patient had the following side effects: erythema, pruritus, pyrexia, rash maculo-papular, skin plaque. During the same period patient was treated with CEFPODOXIME PROXETIL (Po) (View Cefpodoxime Proxetil Review and Cefpodoxime Proxetil Label ), ACETYLCYSTEINE (Po) (View Acetylcysteine Review and Acetylcysteine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5694380-7 | Acute Pulmonary Oedema, Body Temperature Increased, Cardiomegaly, Fatigue, Flushing, Forceps Delivery, Myocarditis, No Therapeutic Response
on Mar 28, 2008 Female patient from FRANCE , 31 years of age, was diagnosed with neonatal respiratory distress syndrome, tocolysis and was treated with Celestone (View Usage). After Celestone was administered, patient had the following side effects: acute pulmonary oedema, body temperature increased, cardiomegaly, fatigue, flushing, forceps delivery, myocarditis, no therapeutic response. Celestone dosage: 12 Mg; Qd; Im. During the same period patient was treated with NICARDIPINE HCL (2 Mg;qh;iv; 4 Mg;qh;iv) (View Nicardipine Hcl Review and Nicardipine Hcl Label ), NIFEDIPINE (60 Mg;qd;po; 20 Mg;qd) (View Nifedipine Review and Nifedipine Label ), ATOSIBAN (ATOSIBAN) (6.75 Mg; Iv; 18 Mg;qh;iv; 6 Mg;qh;iv) (View Atosiban (atosiban) Review and Atosiban (atosiban) Label ).

5683548-1 | Body Temperature Decreased, Cardiomegaly, Ejection Fraction Decreased, Fatigue, Hypokinesia, Myocarditis, Oedema Peripheral, Pericardial Effusion, Pleural Effusion
on Mar 21, 2008 Female patient from FRANCE , 31 years of age, was diagnosed with neonatal respiratory distress syndrome, tocolysis and was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature decreased, cardiomegaly, ejection fraction decreased, fatigue, hypokinesia, myocarditis, oedema peripheral, pericardial effusion, pleural effusion. Celestone dosage: 12 Mg; Qd; Im. During the same period patient was treated with NICARDIPINE HCL (2 Mg; Qh; Iv, 4 Mg; Qh; Iv) (View Nicardipine Hcl Review and Nicardipine Hcl Label ), NIFEDIPINE (60 Mg; Qd; Po, 20 Mg; Qd;) (View Nifedipine Review and Nifedipine Label ), ATOSIBAN (ATOSIBAN) (6.75 Mg; ; Iv, 18 Mg; Qh; Iv, 6 Mg; Qh; Iv) (View Atosiban (atosiban) Review and Atosiban (atosiban) Label ).

5679854-7 | Acute Respiratory Distress Syndrome, Circulatory Collapse, Hypoxia, Procedural Hypotension
Patient was taking Celestone (View Usage). Patient had the following side effects: acute respiratory distress syndrome, circulatory collapse, hypoxia, procedural hypotension on Mar 14, 2008 from FRANCE Additional patient health information: Male patient , 65 years of age, was diagnosed with anaesthesia and. Celestone dosage: ; Once; Iv. During the same period patient was treated with DIPRIVAN (280 Mg; Once; Iv) (View Diprivan Review and Diprivan Label ), SUFENTANIL (SUFENTANIL) (; Once; Iv) (View Sufentanil (sufentanil) Review and Sufentanil (sufentanil) Label ), TRACRIUM (30 Mg; Once; Iv) (View Tracrium Review and Tracrium Label ), ATROPINE (; Once; Iv) (View Atropine Review and Atropine Label ). Patient was hospitalized.

5656216-X | Acute Pulmonary Oedema, Body Temperature Increased, Cardiomegaly, Fatigue, Flushing, Myocarditis, No Therapeutic Response, Oedema Peripheral
Adverse event was reported on Feb 29, 2008 by a Female patient taking Celestone (View Usage) (Dosage: 12 Mg; Qd; Im) was diagnosed with neonatal respiratory distress syndrome, tocolysis and. Location: FRANCE , 31 years of age, After Celestone was administered, patient had the following side effects: acute pulmonary oedema, body temperature increased, cardiomegaly, fatigue, flushing, myocarditis, no therapeutic response, oedema peripheral. During the same period patient was treated with LOXEN (NICARDIPINE HYDROCHLORIDE) (2 Mg; Qh; Iv, 4 Mg; Qh; Iv) (View Loxen (nicardipine Hydrochloride) Review and Loxen (nicardipine Hydrochloride) Label ), ADALATE (NIFEDIPINE) (60 Mg; Qd; Po, 20 Mg; Qd;) (View Adalate (nifedipine) Review and Adalate (nifedipine) Label ), ATOSIBAN (ATOSIBAN) (6.75 Mg; ; Iv, 18 Mg; Qh; Iv, 6 Mg; Qh; Iv) (View Atosiban (atosiban) Review and Atosiban (atosiban) Label ).

5594672-6 | Acute Pulmonary Oedema, Akinesia, Chest X-ray Abnormal, Echocardiogram Abnormal, Ejection Fraction Decreased, Flushing, Hypoxia, No Therapeutic Response
on Jan 10, 2008 Female patient from FRANCE , 31 years of age, was diagnosed with neonatal respiratory distress syndrome, tocolysis and was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, akinesia, chest x-ray abnormal, echocardiogram abnormal, ejection fraction decreased, flushing, hypoxia, no therapeutic response. Celestone dosage: 12 Mg; Qd; Im. During the same period patient was treated with NICARDIPINE HCL (2 Mg; Qh; Iv; 4 Mg; Qh; Iv) (View Nicardipine Hcl Review and Nicardipine Hcl Label ), ADALATE (NIFEDIPINE) (60 Mg; Qd; Po; 20 Mg; Qd) (View Adalate (nifedipine) Review and Adalate (nifedipine) Label ), ATOSIBAN (ATOSIBAN) (75 Mg; Iv; 18 Mg; Qh; Iv; 6 Mg; Qh; Iv) (View Atosiban (atosiban) Review and Atosiban (atosiban) Label ).

5578569-3 | Genital Haemorrhage
on Dec 19, 2007 Female patient from FRANCE , 42 years of age, was treated with Celestone (View Usage). Patient had the following side effects: genital haemorrhage. Celestone dosage: 1 Df;once;ia.

5527638-2 | Dizziness, Dyspnoea, Hypertension, Ocular Hyperaemia
Patient was taking Celestone (View Usage). After Celestone was administered, patient had the following side effects: dizziness (What is dizziness?), dyspnoea, hypertension, ocular hyperaemia on Nov 14, 2007 from MOROCCO Additional patient health information: Female patient , 56 years of age, weighting 138.9 lb, was diagnosed with bronchitis (What is bronchitis?) and. Celestone dosage: 4 Mg;qm;im. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

5515863-6 | Paraesthesia, Swelling
Adverse event was reported on Nov 05, 2007 by a Female patient taking Celestone (View Usage) (Dosage: 4 Mg; Qd; Po) was diagnosed with bronchopneumopathy and. Location: FRANCE , weighting 163.1 lb, Patient experienced the following unwanted or unexpected effects: paraesthesia, swelling. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ).

5410393-4 | Abasia, Abdominal Distension, Abdominal Pain, Agitation, Aphonia, Asthenia, Back Pain, Cardiac Disorder, Chest Discomfort
on Jul 31, 2007 Female patient from UNITED STATES , 60 years of age, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Celestone (View Usage). Patient had the following side effects: abasia, abdominal distension, abdominal pain (What is abdominal pain?), agitation, aphonia, asthenia, back pain (What is back pain?), cardiac disorder, chest discomfort. Celestone dosage: 2 Ml;once, 1 Ml;once. During the same period patient was treated with MINAX (View Minax Review and Minax Label ), OGEN (View Ogen Review and Ogen Label ), SEREPAX (View Serepax Review and Serepax Label ), POLARAMINE (View Polaramine Review and Polaramine Label ), FEBRIDOL (View Febridol Review and Febridol Label ), PANALGESIC (View Panalgesic Review and Panalgesic Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ).

5355841-3 | Chills, Headache, Injection Site Abscess, Injection Site Nerve Damage, Injection Site Reaction, Mobility Decreased, Pain, Pyrexia
on Jun 11, 2007 Female patient from UNITED STATES , weighting 160.0 lb, was diagnosed with sinusitis (What is sinusitis?) and was treated with Celestone (View Usage). After Celestone was administered, patient had the following side effects: chills, headache (What is headache?), injection site abscess, injection site nerve damage, injection site reaction, mobility decreased, pain (What is pain?), pyrexia. Celestone dosage: One Injection.

5330576-1 | Erythema, Tachycardia, Vasodilatation
Patient was taking Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, tachycardia, vasodilatation on May 14, 2007 from FRANCE Additional patient health information: Female patient , 29 years of age, . Celestone dosage: 6 Mg;qd;iv. During the same period patient was treated with AUGMENTIN '200' (2 Gm;qd;iv) (View Augmentin '200' Review and Augmentin '200' Label ). Patient was hospitalized.

5314601-X | Acute Pulmonary Oedema, Lung Disorder, Sinus Tachycardia
Adverse event was reported on Apr 12, 2007 by a Female patient taking Celestone (View Usage) (Dosage: 12 Mg; Qd; Iv) was diagnosed with premature labour and. Location: FRANCE , 22 years of age, Patient had the following side effects: acute pulmonary oedema, lung disorder, sinus tachycardia. During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (Iv) (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ). Patient was hospitalized.

5288733-9 | Rhabdomyolysis
on Mar 23, 2007 Male patient from JAPAN , 13 years of age, was diagnosed with urticaria and was treated with Celestone (View Usage). After Celestone was administered, patient had the following side effects: rhabdomyolysis. Celestone dosage: 1 Df; Po. During the same period patient was treated with ALLEGRA (View Allegra Review and Allegra Label ).

5255129-5 | Chronic Sinusitis, Haematuria, Hepatitis, Nasal Polyps
on Feb 20, 2007 Male patient from JAPAN , 72 years of age, weighting 165.3 lb, was diagnosed with chronic sinusitis, hypertension and was treated with Celestone (View Usage). Patient experienced the following unwanted or unexpected effects: chronic sinusitis, haematuria, hepatitis (What is hepatitis?), nasal polyps. Celestone dosage: 2 Df;qd;po. During the same period patient was treated with CLARITHROMYCIN (400 Mg; Po) (View Clarithromycin Review and Clarithromycin Label ), RIZABEN (TRANILAST) (200 Mg; Po) (View Rizaben (tranilast) Review and Rizaben (tranilast) Label ), MUCOSTA (REBAMIPIDE) (300 Mg; Po) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ), DIOVAN (40 Mg; Po) (View Diovan Review and Diovan Label ). Patient was hospitalized.

5252888-2 | Major Depression, Suicidal Ideation
Patient was taking Celestone (View Usage). Patient had the following side effects: major depression, suicidal ideation on Feb 15, 2007 from RUSSIAN FEDERATION Additional patient health information: Female patient , 18 years of age, was diagnosed with systemic lupus erythematosus and. Celestone dosage: See Image. During the same period patient was treated with CYCLOPHOSPHAN (View Cyclophosphan Review and Cyclophosphan Label ), PLACVENILI (View Placvenili Review and Placvenili Label ).